Form 8-K - Current report:
SEC Accession No. 0001299933-12-000830
Filing Date
2012-04-11
Accepted
2012-04-11 17:09:07
Documents
1
Period of Report
2012-04-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_44706.htm 8-K 9778
  Complete submission text file 0001299933-12-000830.txt   10781
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 12754802
SIC: 2834 Pharmaceutical Preparations